Reuters logo
5 年前
Dainippon Sumitomo Pharma to buy U.S. bio-venture
2012年2月29日 / 早上7点58分 / 5 年前

Dainippon Sumitomo Pharma to buy U.S. bio-venture

1 分钟阅读

TOKYO, Feb 29 (Reuters) - Dainippon Sumitomo Pharma Co said on Wednesday it will buy U.S. bio-venture Boston Biomedical Inc. for $200 million.

The Japanese drugmaker also said it will make up to $540 million in milestone payments for two experimental medicines to Boston Biomedical, which specialises in cancer drugs.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below